sponsored links

J&J sees continued supply shortages of cancer drug (Reuters)

Sponsored Links

Reuters – Johnson & Johnson has told doctors it expects a limited supply of its Doxil cancer drug to become available within the next six weeks, but warned the amount would not be sufficient for all patients currently on waiting lists.

View full post on Yahoo! News: Health News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.